Use of chemical hair straighteners (“relaxers”) is associated with higher risks of hormonally mediated conditions. We hypothesized users of relaxers would have a higher prevalence of abnormal uterine bleeding (AUB) and dysmenorrhea.
Materials and Methods:
We analyzed baseline data from Pregnancy Study Online, an internet-based preconception cohort study of North American pregnancy planners. We included 14,366 participants aged 21–39 years who enrolled during 2014–2024 and reported on their typical menstrual cycle characteristics when not using hormones. We collected data on history of use, age at first use, frequency per year, duration of use, and number of burns. We defined AUB as cycle length <24 or >38 days, flow ≥ 7 days, irregular cycles, and/or heavy flow (>30 pads/tampons per menses). We defined dysmenorrhea as severe cramps requiring medication and bed rest. We used modified Poisson regression models to estimate prevalence ratios (PRs) and 95% confidence intervals (CIs) for the associations of relaxer use with AUB and dysmenorrhea, adjusted for potential confounders.
Results:
Overall, 2% of participants were current users and 10% were former users of relaxers. The frequencies of AUB and dysmenorrhea were 31% and 8%, respectively. PRs for current (versus never) relaxer use were 1.16 (95% CI: 1.00–1.33) for AUB and 1.30 (95% CI: 0.94–1.80) for dysmenorrhea. Participants who reported ever experiencing burns (versus never use) had a higher prevalence of dysmenorrhea (1–4 burns: PR = 1.42, 95% CI: 1.04–1.93; ≥5 burns: PR = 1.46, 95% CI: 1.00–2.13).
Conclusion:
Relaxer use was associated with a higher prevalence of menstrual disturbances.
RosenbergL, BoggsDA, Adams-CampbellLL, et al.Hair relaxers not associated with breast cancer risk: Evidence from the black women’s health study. Cancer Epidemiol Biomarkers Prev2007;16(5):1035–1037; doi: 10.1158/1055-9965.EPI-06-0946
2.
EdwardsL, AhmedL, MartinezL, et al.Beauty inside out: Examining beauty product use among diverse women and femme-identifying individuals in Northern Manhattan and South Bronx through an environmental justice framework. Environ Justice2023;16(6):449–460; doi: 10.1089/env.2022.0053
3.
LlanosAAM, RabkinA, BanderaEV, et al.Hair product use and breast cancer risk among African American and white women. Carcinogenesis2017;38(9):883–892; doi: 10.1093/carcin/bgx060
4.
Blackmore-PrinceC, HarlowSD, GargiulloP, et al.Chemical hair treatments and adverse pregnancy outcome among black women in central North Carolina. Am J Epidemiol1999;149(8):712–716; doi: 10.1093/oxfordjournals.aje.a009879
5.
James-ToddT, SenieR, TerryMB. Racial/ethnic differences in hormonally-active hair product use: A plausible risk factor for health disparities. J Immigr Minor Health2012;14(3):506–511; doi: 10.1007/s10903-011-9482-5
6.
WiseLA, WangTR, NcubeCN, et al.Use of chemical hair straighteners and fecundability in a North American preconception cohort. Am J Epidemiol2023;192(7):1066–1080; doi: 10.1093/aje/kwad079
7.
GastonSA, James-ToddT, HarmonQ, et al.Chemical/straightening and other hair product usage during childhood, adolescence, and adulthood among African-American women: Potential implications for health. J Expo Sci Environ Epidemiol2020;30(1):86–96; doi: 10.1038/s41370-019-0186-6
8.
ZotaAR, ShamasunderB. The environmental injustice of beauty: Framing chemical exposures from beauty products as a health disparities concern. Am J Obstet Gynecol2017;217(4):418 e1–418.e6; doi: 10.1016/j.ajog.2017.07.020
9.
McDonaldJA, LlanosAAM, MortonT, et al.The environmental injustice of beauty products: Toward clean and equitable beauty. Am J Public Health2022;112(1):50–53; doi: 10.2105/AJPH.2021.306606
10.
MbilishakaAM, ClemonsK, HudlinM, et al.Don’t get it twisted: Untangling the psychology of hair discrimination within black communities. Am J Orthopsychiatry2020;90(5):590–599; doi: 10.1037/ort0000468
11.
LeeMS, NambudiriVE. The CROWN act and dermatology: Taking a stand against race-based hair discrimination. J Am Acad Dermatol2021;84(4):1181–1182; doi: 10.1016/j.jaad.2020.11.065
12.
NkimbengM, Malaika RumalaBB, RichardsonCM, et al.The person beneath the hair: Hair discrimination, health, and well-being. Health Equity2023;7(1):406–410; doi: 10.1089/heq.2022.0118
13.
Miranda-VilelaAL, BotelhoAJ, MuehlmannLA. An overview of chemical straightening of human hair: Technical aspects, potential risks to hair fibre and health and legal issues. Int J Cosmet Sci2014;36(1):2–11; doi: 10.1111/ics.12093
HelmJS, NishiokaM, BrodyJG, et al.Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by black women. Environ Res2018;165:448–458; doi: 10.1016/j.envres.2018.03.030
16.
PierceJS, AbelmannA, SpicerLJ, et al.Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg2011;8(11):686–699; doi: 10.1080/15459624.2011.626259
17.
OdukuduFB, AyenimoJG, AdekunleAS, et al.Safety evaluation of heavy metals exposure from consumer products. Int J Consum Stud2014;38(1):25–34; doi: 10.1111/ijcs.12061
18.
ErnstoffAS, FantkeP, CsiszarSA, et al.Multi-pathway exposure modeling of chemicals in cosmetics with application to shampoo. Environ Int2016;92–93:87–96; doi: 10.1016/j.envint.2016.03.014
19.
BormannJL, MaibachHI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutan Ocul Toxicol2020;39(3):213–222; doi: 10.1080/15569527.2020.1787434
20.
Hatsbach de PaulaJN, BasílioFMA, Mulinari-BrennerFA. Effects of chemical straighteners on the hair shaft and scalp. An Bras Dermatol2022;97(2):193–203; doi: 10.1016/j.abd.2021.02.010
21.
KezicS, NielsenJB. Absorption of chemicals through compromised skin. Int Arch Occup Environ Health2009;82(6):677–688; doi: 10.1007/s00420-009-0405-x
22.
James-ToddT, TerryMB, Rich-EdwardsJ, et al.Childhood hair product use and earlier age at menarche in a racially diverse study population: A pilot study. Ann Epidemiol2011;21(6):461–465; doi: 10.1016/j.annepidem.2011.01.009
23.
McDonaldJA, TehranifarP, FlomJD, et al.Hair product use, age at menarche and mammographic breast density in multiethnic urban women. Environ Health2018;17(1):1; doi: 10.1186/s12940-017-0345-y
24.
WiseLA, PalmerJR, ReichD, et al.Hair relaxer use and risk of uterine leiomyomata in African-American women. Am J Epidemiol2012;175(5):432–440; doi: 10.1093/aje/kwr351
25.
OgunsinaK, O’BrienKM, WhiteAJ, et al.Hair straightener use in relation to prevalent and incident fibroids in the sister study with a focus on black women. Environ Health Perspect2025;133(1):17004; doi: 10.1289/EHP14493
26.
BrintonLA, FigueroaJD, AnsongD, et al.Skin lighteners and hair relaxers as risk factors for breast cancer: Results from the Ghana breast health study. Carcinogenesis2018;39(4):571–579; doi: 10.1093/carcin/bgy002
27.
EberleCE, SandlerDP, TaylorKW, et al.Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women. Int J Cancer2020;147(2):383–391; doi: 10.1002/ijc.32738
28.
CooganPF, RosenbergL, PalmerJR, et al.Hair product use and breast cancer incidence in the black women’s health study. Carcinogenesis2021;42(7):924–930; doi: 10.1093/carcin/bgab041
29.
WhiteAJ, GregoireAM, TaylorKW, et al.Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk. Int J Cancer2021;148(9):2255–2263; doi: 10.1002/ijc.33413
30.
WhiteAJ, SandlerDP, GastonSA, et al.Use of hair products in relation to ovarian cancer risk. Carcinogenesis2021;42(9):1189–1195; doi: 10.1093/carcin/bgab056
31.
ChangCJ, O’BrienKM, KeilAP, et al.Use of straighteners and other hair products and incident uterine cancer. J Natl Cancer Inst2022;114(12):1636–1645; doi: 10.1093/jnci/djac165
32.
BertrandKA, DelpL, CooganPF, et al.Hair relaxer use and risk of uterine cancer in the black women’s health study. Environ Res2023;239(Pt 1):117228; doi: 10.1016/j.envres.2023.117228
33.
HarlowSD, EphrossSA. Epidemiology of menstruation and its relevance to women’s health. Epidemiol Rev1995;17(2):265–286; doi: 10.1093/oxfordjournals.epirev.a036193
34.
MunroMG, FIGO Committee on Menstrual Disorders. Abnormal uterine bleeding: A well-travelled path to iron deficiency and anemia. Int J Gynaecol Obstet2020;150(3):275–277; doi: 10.1002/ijgo.13180
35.
LiuZ, DoanQV, BlumenthalP, et al.A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health2007;10(3):183–194; doi: 10.1111/j.1524-4733.2007.00168.x
36.
MumfordSL, SteinerAZ, PollackAZ, et al.The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. J Clin Endocrinol Metab2012;97(10):E1871–E9; doi: 10.1210/jc.2012-1350
37.
MunroMG, CritchleyHOD, FraserIS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet2018;143(3):393–408; doi: 10.1002/ijgo.12666
38.
JuH, JonesM, MishraG. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev2014;36:104–113; doi: 10.1093/epirev/mxt009
39.
ArmourM, ParryK, ManoharN, et al.The prevalence and academic impact of dysmenorrhea in 21,573 young women: A systematic review and meta-analysis. J Womens Health (Larchmt)2019;28(8):1161–1171; doi: 10.1089/jwh.2018.7615
40.
WiseLA, RothmanKJ, MikkelsenEM, et al.Design and conduct of an internet-based preconception cohort study in North America: Pregnancy study online. Paediatr Perinat Epidemiol2015;29(4):360–371; doi: 10.1111/ppe.12201
41.
RosenbergL, WiseLA, PalmerJR. Hair-relaxer use and risk of preterm birth among African-American women. Ethn Dis2005;15(4):768–772.
42.
MbilishakaAM, HudlinM. “I remember my first relaxer”: Black women voicing psychologically engrained practices of chemical hair straightening. J Black Psychol2023;49(5):716–741.
43.
Milady. Chapter 15. Chemical Texture Services. In: Milady Standard Cosmetology, 14th edn. Cengage Learning, Inc.; 2023.
44.
CohenS, KamarckT, MermelsteinR. A global measure of perceived stress. J Health Soc Behav1983;24(4):385; doi: 10.2307/2136404
45.
BechP. Quality of life instruments in depression. Eur Psychiatry1997;12(4):194–198; doi: 10.1016/S0924-9338(97)89104-3
46.
BaileyZD, KriegerN, AgénorM, et al.Structural racism and health inequities in the USA: Evidence and interventions. Lancet2017;389(10077):1453–1463; doi: 10.1016/S0140-6736(17)30569-X
47.
JonesCP. Levels of racism: A theoretic framework and a gardener’s tale. Am J Public Health2000;90(8):1212–1215; doi: 10.2105/ajph.90.8.1212
ZhangX, YuY, GuY, et al.In vitro determination of transdermal permeation of synthetic musks and estimated dermal uptake through usage of personal care products. Chemosphere2017;173:417–424; doi: 10.1016/j.chemosphere.2017.01.001
52.
PrasanthiD, LakshmiPK. Terpenes: Effect of lipophilicity in enhancing transdermal delivery of alfuzosin hydrochloride. J Adv Pharm Technol Res2012;3(4):216–223; doi: 10.4103/2231-4040.104712
53.
BlatterBM, ZielhuisGA. Menstrual disorders due to chemical exposure among hairdressers. Occup Med (Lond)1993;43(2):105–106; doi: 10.1093/occmed/43.2.105
54.
KersemaekersWM, RoeleveldN, ZielhuisGA. Reproductive disorders due to chemical exposure among hairdressers. Scand J Work Environ Health1995;21(5):325–334; doi: 10.5271/sjweh.46
55.
RondaE, GarciaAM, Sanchez-PayaJ, et al.Menstrual disorders and subfertility in Spanish hairdressers. Eur J Obstet Gynecol Reprod Biol2009;147(1):61–64; doi: 10.1016/j.ejogrb.2009.07.020
56.
GanHF, MengXS, SongCH, et al.A survey on health effects in a human population exposed to permanent-waving solution containing thioglycolic acid. J Occup Health2003;45(6):400–404; doi: 10.1539/joh.45.400
57.
GallicchioL, MillerS, GreeneT, et al.Menstrual cycle abnormalities among cosmetologists: The reproductive outcomes in salon employees (ROSE) study. Reprod Sci2010;17(1):20–28; doi: 10.1177/1933719109345163
58.
PakVM, PowersM, LiuJ. Occupational chemical exposures among cosmetologists: Risk of reproductive disorders. Workplace Health Saf2013;61(12):522–528; quiz 529; doi: 10.1177/216507991306101204
59.
ManeliMH, SmithP, KhumaloNP. Elevated formaldehyde concentration in “Brazilian keratin type” hair-straightening products: A cross-sectional study. J Am Acad Dermatol2014;70(2):276–280; doi: 10.1016/j.jaad.2013.10.023
60.
BackRA, YamamotoS. The gas-phase photochemistry and thermal decomposition of glyoxylic acid. Can J Chem1985;63(2):542–548; doi: 10.1139/v85-088
61.
CzernychR, ChraniukM, ZagożdżonP, et al.Characterization of estrogenic and androgenic activity of phthalates by the XenoScreen YES/YAS in vitro assay. Environ Toxicol Pharmacol2017;53:95–104; doi: 10.1016/j.etap.2017.05.010
62.
ChenJ, AhnKC, GeeNA, et al.Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol Appl Pharmacol2007;221(3):278–284; doi: 10.1016/j.taap.2007.03.015
63.
WangX, LuoN, XuZ, et al.The estrogenic proliferative effects of two alkylphenols and a preliminary mechanism exploration in MCF-7 breast cancer cells. Environ Toxicol2020;35(5):628–638; doi: 10.1002/tox.22898
64.
Bonefeld-JorgensenEC, LongM, HofmeisterMV, et al.Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: New data and a brief review. Environ Health Perspect2007;115(Suppl 1):69–76; doi: 10.1289/ehp.9368
65.
QuinnAL, ReganJM, TobinJM, et al.In vitro and in vivo evaluation of the estrogenic, androgenic, and progestagenic potential of two cyclic siloxanes. Toxicol Sci2007;96(1):145–153; doi: 10.1093/toxsci/kfl185
66.
ChenX, XuS, TanT, et al.Toxicity and estrogenic endocrine disrupting activity of phthalates and their mixtures. Int J Environ Res Public Health2014;11(3):3156–3168; doi: 10.3390/ijerph110303156
67.
RoutledgeEJ, ParkerJ, OdumJ, et al.Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol1998;153(1):12–19.
68.
James-ToddT, ConnollyL, PrestonEV, et al.Hormonal activity in commonly used black hair care products: Evaluating hormone disruption as a plausible contribution to health disparities. J Expo Sci Environ Epidemiol2021;31(3):476–486; doi: 10.1038/s41370-021-00335-3
69.
WangZ, RenX, WangD, et al.Effects of thioglycolic acid on parthenogenetic activation of Xenopus oocytes. PLoS One2011;6(1):e16220; doi: 10.1371/journal.pone.0016220
70.
DuongA, SteinmausC, McHaleCM, et al.Reproductive and developmental toxicity of formaldehyde: A systematic review. Mutat Res2011;728(3):118–138; doi: 10.1016/j.mrrev.2011.07.003
71.
HassaniS, NamvarM, GhoreishvandiM, et al.Menstrual disturbances and hormonal changes in women workers exposed to a mixture of organic solvents in a pharmaceutical company. Med J Islam Repub Iran2014;28:156.
72.
LiH, HartJE, MahalingaiahS, et al.Environmental exposures and anti-Mullerian hormone: A mixture analysis in the nurses’ health study II. Epidemiology2023;34(1):150–161; doi: 10.1097/EDE.0000000000001547
73.
NoblesCJ, MendolaP, KimK, et al.Preconception phthalate exposure and women’s reproductive health: Pregnancy, pregnancy loss, and underlying mechanisms. Environ Health Perspect2023;131(12):127013; doi: 10.1289/EHP12287
74.
PollackAZ, MumfordSL, KrallJR, et al.Exposure to bisphenol A, chlorophenols, benzophenones, and parabens in relation to reproductive hormones in healthy women: A chemical mixture approach. Environ Int2018;120:137–144; doi: 10.1016/j.envint.2018.07.028
75.
JukicAM, CalafatAM, McConnaugheyDR, et al.Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss. Environ Health Perspect2016;124(3):321–328; doi: 10.1289/ehp.1408164
76.
NishihamaY, YoshinagaJ, IidaA, et al.Association between paraben exposure and menstrual cycle in female university students in Japan. Reprod Toxicol2016;63:107–113; doi: 10.1016/j.reprotox.2016.05.010
77.
MaY, LiuH, WuJ, et al.The adverse health effects of bisphenol A and related toxicity mechanisms. Environ Res2019;176:108575; doi: 10.1016/j.envres.2019.108575
78.
SafarAM, Santacruz-MarquezR, LawsMJ, et al.Dietary exposure to an environmentally relevant phthalate mixture alters follicle dynamics, hormone levels, ovarian gene expression, and pituitary gene expression in female mice. Reprod Toxicol2023;122:108489; doi: 10.1016/j.reprotox.2023.108489
79.
PulcastroH, Ziv-GalA. Parabens effects on female reproductive health—Review of evidence from epidemiological and rodent-based studies. Reprod Toxicol2024;128:108636; doi: 10.1016/j.reprotox.2024.108636
80.
FletcherEJ, Santacruz-MarquezR, MourikesVE, et al.Effects of phthalate mixtures on ovarian folliculogenesis and steroidogenesis. Toxics2022;10(5):251; doi: 10.3390/toxics10050251
81.
CrawfordK, HernandezC. A review of hair care products for black individuals. Cutis2014;93(6):289–293.
82.
de Sa DiasTC, BabyAR, KanekoTM, et al.Relaxing/straightening of Afro-ethnic hair: Historical overview. J Cosmet Dermatol2007;6(1):2–5; doi: 10.1111/j.1473-2165.2007.00294.x
83.
TackeyRN, BryantH, ParksFM. Cytokine expression correlates with differential sensory perception between lye and no-lye relaxers. J Cosmet Sci2013;64(2):111–117.
84.
BorreroS, NikolajskiC, SteinbergJR, et al.“It just happens”: A qualitative study exploring low-income women’s perspectives on pregnancy intention and planning. Contraception2015;91(2):150–156; doi: 10.1016/j.contraception.2014.09.014
85.
HernandezND, ChandlerR, NavaN, et al.Young adult US-born Latina women’s thoughts, feelings and beliefs about unintended pregnancy. Cult Health Sex2020;22(8):920–936; doi: 10.1080/13691058.2019.1642517
86.
AikenAR, BorreroS, CallegariLS, et al.Rethinking the pregnancy planning paradigm: Unintended conceptions or unrepresentative concepts? Perspect Sex Reprod Health2016;48(3):147–151; doi: 10.1363/48e10316
87.
ManzeMG, RomeroDR. Revisiting the association between race, ethnicity, and beliefs about pregnancy. Ethn Dis2020;30(4):525–532; doi: 10.18865/ed.30.4.525. Available from: https://ethndis.org/archive/archive-regular-issues.html
88.
ArteagaS, CatonL, GomezAM. Planned, unplanned and in-between: The meaning and context of pregnancy planning for young people. Contraception2019;99(1):16–21; doi: 10.1016/j.contraception.2018.08.012
89.
SnowM, VranichTM, PerinJ, et al.Estimates of infertility in the United States: 1995-2019. Fertil Steril2022;118(3):560–567; doi: 10.1016/j.fertnstert.2022.05.018
90.
ThomaME, McLainAC, LouisJF, et al.Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril2013;99(5):1324–1331.e1; doi: 10.1016/j.fertnstert.2012.11.037
91.
BairdDD, DunsonDB, HillMC, et al.High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol2003;188(1):100–107; doi: 10.1067/mob.2003.99
92.
KatonJG, PlowdenTC, MarshEE. Racial disparities in uterine fibroids and endometriosis: A systematic review and application of social, structural, and political context. Fertil Steril2023;119(3):355–363; doi: 10.1016/j.fertnstert.2023.01.022
93.
StewartEA, NicholsonWK, BradleyL, et al.The burden of uterine fibroids for African-American women: Results of a national survey. J Womens Health (Larchmt)2013;22(10):807–816; doi: 10.1089/jwh.2013.4334
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
